Dialysis-induced myocardial stunning: the other side of the cardiorenal syndrome.

Cardiorenal syndrome is an umbrella term describing the range of interactions between the heart and kidneys. Commonly, this focuses on the potential for reduced renal function as a consequence of heart disease and the impact of reduced renal functional reserve on the heart. Importantly, these interactions include both consequences of the disease state and those arising from therapeutic interventions directed at the cardiorenal axis. This article focuses on the potential impact of dialysis treatment, which generates intermittent circulatory stress and results in both acute and chronic adverse cardiovascular effects. This largely unappreciated dimension of the cardiorenal interaction in patients with end-stage renal failure is common, associated with a significant increase in mortality, and may be amenable to a variety of therapeutic approaches in this population characterized by particularly significant clinical management challenges.

[1]  C. McIntyre,et al.  Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[2]  C. McIntyre,et al.  Individualised Dialysate Temperature Improves Intradialytic Haemodynamics and Abrogates Haemodialysis-Induced Myocardial Stunning, without Compromising Tolerability , 2011, Blood Purification.

[3]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[4]  S. Solomon,et al.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. , 2009, The New England journal of medicine.

[5]  E. Ritz,et al.  Cardiovascular problems on hemodialysis: current deficits and potential improvement. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[6]  N. Selby,et al.  Hemodialysis-induced cardiac injury: determinants and associated outcomes. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[7]  John G F Cleland,et al.  Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. , 2007, Journal of cardiac failure.

[8]  E. Ritz,et al.  Dialysis, cardiovascular disease, and the future , 2007 .

[9]  Huiman Barnhart,et al.  Correction of anemia with epoetin alfa in chronic kidney disease. , 2006, The New England journal of medicine.

[10]  P. Schirmacher,et al.  Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[11]  N. Selby,et al.  Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[12]  F. Zannad,et al.  Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. , 2006, Kidney international.

[13]  Harlan M Krumholz,et al.  Renal impairment and outcomes in heart failure: systematic review and meta-analysis. , 2006, Journal of the American College of Cardiology.

[14]  N. Selby,et al.  Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  C. McIntyre,et al.  Vascular calcification and cardiovascular function in chronic kidney disease. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  J. Keyser,et al.  Myocardial calcification: a rare cause of diastolic dysfunction , 2006, Heart.

[17]  C. Herzog Sudden cardiac death and acute myocardial infarction in dialysis patients: perspectives of a cardiologist. , 2005, Seminars in nephrology.

[18]  W. März,et al.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.

[19]  V. Jha,et al.  Silent Myocardial Ischemia and High-Grade Ventricular Arrhythmias in Patients on Maintenance Hemodialysis , 2005, Renal failure.

[20]  H. Samady,et al.  Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. , 2004, American heart journal.

[21]  G. London,et al.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  C. Herzog Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. , 2003, Kidney international. Supplement.

[23]  N. Powe,et al.  Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. , 2002, Journal of the American Society of Nephrology : JASN.

[24]  Sharon M Moe,et al.  Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. , 2002, Kidney international.

[25]  J. Blacher,et al.  Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease , 2001, Hypertension.

[26]  M. Caty,et al.  Intestinal and hemodynamic impairment following mesenteric ischemia/reperfusion. , 2001, The Journal of surgical research.

[27]  R. Elashoff,et al.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. , 2000, The New England journal of medicine.

[28]  N. Westerhof,et al.  Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  J E Parrillo,et al.  Myocardial dysfunction in septic shock. , 2000, Critical care clinics.

[30]  E. Ritz,et al.  Myocyte/capillary mismatch in the heart of uremic patients. , 1998, Journal of the American Society of Nephrology : JASN.

[31]  J. Daugirdas,et al.  Splanchnic erythrocyte content decreases during hemodialysis: a new compensatory mechanism for hypovolemia. , 1997, Kidney international.

[32]  Y. Sugishita,et al.  Chronically decreased aortic distensibility causes deterioration of coronary perfusion during increased left ventricular contraction. , 1994, Journal of the American College of Cardiology.

[33]  E. Braunwald,et al.  The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction , 1982, Circulation.

[34]  P. Li,et al.  Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[35]  P. Ponikowski,et al.  Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). , 2010, Contributions to nephrology.

[36]  N. Selby,et al.  Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[37]  A. Langer,et al.  Myocardial alterations during hemodialysis: insights from new noninvasive technology. , 1994, American journal of nephrology.

[38]  R. Wilson,et al.  Gastric intramucosal acidosis in patients with chronic kidney failure. , 1993, Surgery.

[39]  R. Ritz,et al.  Incidence of arrhythmias and myocardial ischaemia during haemodialysis and haemofiltration. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.